Childrens’ Urinary MicroRNAs Predict Future Development of Heart or Kidney Diseases
|
By LabMedica International staff writers Posted on 08 Mar 2021 |

Image: Exosomes are 30-150 nanometer extracellular vesicles containing various cargoes such as RNA and proteins (Photo courtesy of Wikimedia Commons)
A panel of microRNAs isolated from the urine of young children was shown to be able to predict the likelihood that a child would develop heart or kidney disease later in life.
MicroRNAs (miRNAs) are short, non-coding RNAs of approximately 20 nucleotides that act as post-transcriptional regulators by modifying target gene expression. Urinary miRNAs are promising biomarkers of subclinical kidney damage or dysfunction because they reflect kidney signaling and histological changes at the molecular level, enabling early detection of chronic kidney disease or progression of acute kidney injury. Urinary miRNAs are also readily obtained and are stable in stored samples.
Exosomes contain the major fraction of miRNA in urine and consequently are an ideal target to probe for molecular biomarkers of kidney diseases. Exosomes are lipid-enclosed extracellular vesicles measuring 30–150 nanometers in diameter that are released by most cells in the body and play an important role in intercellular communication by carrying bioactive molecules (soluble proteins and nucleic acids such as miRNAs) to a target cell. Exosomes in urine are primarily released from renal epithelial cells derived from renal tubular structures and hold promise as one component of a noninvasive liquid biopsy for detecting molecular changes in distinct nephron regions even in the absence of disease. Thus, the study of miRNA expression in exosomes (exo-miR) presents an opportunity in biomarker discovery for blood pressure (BP) regulation and altered renal signaling by identifying new diagnostic biomarkers and therapeutic targets.
In this light, investigators at the Mount Sinai School of Medicine (New York, NY, USA) sought to understand the relationship between urinary exo-miR expression and children's BP and estimated glomerular filtration rate (eGFR) as well as urinary sodium and potassium levels as correlates of heart and kidney health.
For this study, the investigators extracted exo-miRs from urine samples obtained from 88 healthy Mexican children aged four to six years. The study was conducted in Mexico, since children there are considered to be at much higher risk than American children for many heart and kidney problems. Differential centrifugation of spot urines enabled isolation and detection of 193 exo-miRs. Linear regression was then used to analyze the relationship between the extracted exo-miRs and children's BP, eGFR, and urine electrolyte levels.
Results revealed that three exo-miRs had increased expression with urinary sodium, 17 with urinary sodium-to-potassium ratio, and one with decreased estimated glomerular filtration rate.
"Our findings are encouraging for future studies of noninvasive indicators of kidney and heart health, especially for individuals at an increased risk of kidney dysfunction," said senior author Dr. Alison Sanders, assistant professor of environmental medicine, public health, and pediatrics at Mount Sinai School of Medicine. "Further research may discover different combinations of miRNAs that could inform early diagnosis of a wide range of kidney and cardiac diseases. So many children around the world are at risk of developing cardiorenal problems which can impact their health throughout their lives. Assessment of microRNA expression on a targeted scale could present valuable opportunities to detect and intervene with kidney disease before it can progress. That is why we are so encouraged by our team's work in this vital field."
The urinary microRNA study was published in the February 26, 2021, online edition of the journal Epigenomics.
Related Links:
Mount Sinai School of Medicine
MicroRNAs (miRNAs) are short, non-coding RNAs of approximately 20 nucleotides that act as post-transcriptional regulators by modifying target gene expression. Urinary miRNAs are promising biomarkers of subclinical kidney damage or dysfunction because they reflect kidney signaling and histological changes at the molecular level, enabling early detection of chronic kidney disease or progression of acute kidney injury. Urinary miRNAs are also readily obtained and are stable in stored samples.
Exosomes contain the major fraction of miRNA in urine and consequently are an ideal target to probe for molecular biomarkers of kidney diseases. Exosomes are lipid-enclosed extracellular vesicles measuring 30–150 nanometers in diameter that are released by most cells in the body and play an important role in intercellular communication by carrying bioactive molecules (soluble proteins and nucleic acids such as miRNAs) to a target cell. Exosomes in urine are primarily released from renal epithelial cells derived from renal tubular structures and hold promise as one component of a noninvasive liquid biopsy for detecting molecular changes in distinct nephron regions even in the absence of disease. Thus, the study of miRNA expression in exosomes (exo-miR) presents an opportunity in biomarker discovery for blood pressure (BP) regulation and altered renal signaling by identifying new diagnostic biomarkers and therapeutic targets.
In this light, investigators at the Mount Sinai School of Medicine (New York, NY, USA) sought to understand the relationship between urinary exo-miR expression and children's BP and estimated glomerular filtration rate (eGFR) as well as urinary sodium and potassium levels as correlates of heart and kidney health.
For this study, the investigators extracted exo-miRs from urine samples obtained from 88 healthy Mexican children aged four to six years. The study was conducted in Mexico, since children there are considered to be at much higher risk than American children for many heart and kidney problems. Differential centrifugation of spot urines enabled isolation and detection of 193 exo-miRs. Linear regression was then used to analyze the relationship between the extracted exo-miRs and children's BP, eGFR, and urine electrolyte levels.
Results revealed that three exo-miRs had increased expression with urinary sodium, 17 with urinary sodium-to-potassium ratio, and one with decreased estimated glomerular filtration rate.
"Our findings are encouraging for future studies of noninvasive indicators of kidney and heart health, especially for individuals at an increased risk of kidney dysfunction," said senior author Dr. Alison Sanders, assistant professor of environmental medicine, public health, and pediatrics at Mount Sinai School of Medicine. "Further research may discover different combinations of miRNAs that could inform early diagnosis of a wide range of kidney and cardiac diseases. So many children around the world are at risk of developing cardiorenal problems which can impact their health throughout their lives. Assessment of microRNA expression on a targeted scale could present valuable opportunities to detect and intervene with kidney disease before it can progress. That is why we are so encouraged by our team's work in this vital field."
The urinary microRNA study was published in the February 26, 2021, online edition of the journal Epigenomics.
Related Links:
Mount Sinai School of Medicine
Latest Molecular Diagnostics News
- New Respiratory Panel Expands Pathogen Detection to 25 Targets
- Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
- Blood Biomarker Predicts Cognitive Outcomes After Cardiac Arrest
- Liquid Biopsy Enables Faster Diagnosis of Childhood Cancer in Africa
- Blood Test Helps Guide Treatment in Older Women with Breast Cancer
- Rapid Host-Response Test Distinguishes Bacterial and Viral Infections in Minutes
- Liquid Biopsy Method Pinpoints Disease Source From a Single Drop of Blood
- Study Reveals Widespread Errors in Gene Variant Naming
- New Blood Test Aims to Transform Liver Cancer Surveillance
- New Biomarkers Indicate Higher Liver Cancer Risk in Chronic Hepatitis B Patients
- Precision Analyzer Reveals ‘Chameleon Proteins’ Causing Intractable Diseases
- Alzheimer's Blood Marker Could Improve Detection of Heart and Kidney Diseases
- Single Blood Test Predicts Heart Diseases 15 Years Before Onset
- Blood Immune 'Fingerprint' Predicts Side Effects of New Alzheimer's Drug
- Clinical Diagnostic Test Detects Additional Genetic Variants in Acute Leukemia Patients
- Blood Test Predicts Dementia in Women 25 Years Before Symptoms Begin
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








